» Articles » PMID: 17327401

Kit is Essential for PMA-inflammation-induced Mast-cell Accumulation in the Skin

Overview
Journal Blood
Publisher Elsevier
Specialty Hematology
Date 2007 Mar 1
PMID 17327401
Citations 9
Authors
Affiliations
Soon will be listed here.
Abstract

Cutaneous mast cells have important pathogenic roles in skin inflammation, but the signals regulating mast-cell numbers in healthy and inflamed skin are not fully understood. Mast-cell development depends on the receptor tyrosine kinase Kit as shown by a greater than 95% reduction of mast-cell numbers in hypomorphic (Kit(W/Wv)) mutant mice that are widely used as a mast-cell deficiency model. Mast-cell numbers are normally very low in Kit(W/Wv) mice, but numbers can strongly increase under inflammatory conditions. It remains elusive whether this inflammation-driven mast-cell accumulation is mediated by signals transmitted via the Kit(Wv) receptor or by other, Kit-independent stimuli. We show here, using viable Kit- null mice (Kit(W/W)), that Kit is essential for mast-cell accumulation in phorbol-12-myristate-13-acetate (PMA)-treated, chronically inflamed skin. This increase in mast- cell numbers is strongly attenuated in Kit(W/Wv) mice lacking mature lymphocytes (T, B, and natural killer [NK] cells). These data, together with reconstitution experiments, point at a role for lymphocytes in the regulation of mast-cell compartments under limiting Kit signaling. We conclude that inflammation-induced cutaneous mast-cell accumulation is dependent on Kit signaling strength, and, under limiting Kit signals, on cells of the adaptive immune system.

Citing Articles

Anti-inflammatory control of human skin keratinocytes by targeting nuclear transport checkpoint.

Liu Y, Qiao H, Zienkiewicz J, Hawiger J Skin Health Dis. 2024; 4(3):e356.

PMID: 38846687 PMC: 11150741. DOI: 10.1002/ski2.356.


Development and functional testing of a novel in vitro delayed scratch closure assay.

Aw Y, Chen S, Yeo A, Dangerfield J, Mok P Histochem Cell Biol. 2024; 162(3):245-255.

PMID: 38713267 PMC: 11322216. DOI: 10.1007/s00418-024-02292-y.


Genomic control of inflammation in experimental atopic dermatitis.

Liu Y, Zienkiewicz J, Qiao H, Gibson-Corley K, Boyd K, Veach R Sci Rep. 2022; 12(1):18891.

PMID: 36344555 PMC: 9640569. DOI: 10.1038/s41598-022-23042-x.


Topical application of a platelet activating factor receptor agonist suppresses phorbol ester-induced acute and chronic inflammation and has cancer chemopreventive activity in mouse skin.

Sahu R, Rezania S, Ocana J, DaSilva-Arnold S, Bradish J, Richey J PLoS One. 2014; 9(11):e111608.

PMID: 25375862 PMC: 4222871. DOI: 10.1371/journal.pone.0111608.


IL-33/ST2 axis promotes mast cell survival via BCLXL.

Wang J, Kaieda S, Ameri S, Fishgal N, Dwyer D, Dellinger A Proc Natl Acad Sci U S A. 2014; 111(28):10281-6.

PMID: 24982172 PMC: 4104908. DOI: 10.1073/pnas.1404182111.